ArticleJournal of interventional medicine2019

Sorafenib plus hepatic arterial infusion chemotherapy with oxaliplatin versus sorafenib alone for advanced hepatocellular carcinoma.

Yang Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.